Please wait while we open this resource.
K
Clinical reviews
SEMAGLUTIDE AND WALKING CAPACITY IN PEOPLE WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE AND TYPE 2 DIABETES (STRIDE): A PHASE 3B, DOUBLE-BLIND, RANDOMISED, PLACEBO CONTROLLED TRIAL
University of Colorado School of Medicine, Aurora, CO, USA
PDF202514 pages493 KB
Peripheral artery disease is a significant health concern affecting millions worldwide, particularly in individuals with type 2 diabetes. This trial aimed to determine whether semaglutide could enhance walking capacity and overall health-related quality of life in affected patients. The study involved participants with specific criteria related to their diabetes and peripheral artery disease, assessing their response to semaglutide over a 52-week period compared to a placebo.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology